Home > Cardiology > EHRA 2022 > Developments in Devices > Insertable cardiac monitors effective for AF detection in cryptogenic stroke

Insertable cardiac monitors effective for AF detection in cryptogenic stroke

Presented By
Dr Barbara Ratajczak-Tretel, University of Oslo, Norway
Presented by
Barbara Ratajczak-Tretel University of Oslo
Conference
EHRA 2022
Trial
NOR-FIB
Doi
https://doi.org/10.55788/de71f48f
Insertable cardiac monitors (ICMs) demonstrated to be an effective tool for the identification of atrial fibrillation (AF) in patients who experienced a cryptogenic stroke or cryptogenic transient ischaemic attack (TIA) in the NOR-FIB trial. The early start-up of ICMs was accessible to and manageable for clinicians. For the prevention of secondary stroke, detection of the underlying cause is crucial. Prolonged cardiac rhythm monitoring and ≥72 hours of ECG monitoring are guideline-recommended for ruling out underlying AF in patients who experienced a cryptogenic stroke since 2014 and 2020, respectively. However, ICMs are still not implemented in stroke guidelines as the preferred option to perform this task. The NOR-FIB trial (NCT02937077) was designed to identify AF and quantify AF burden in patients who had had a cryptogenic stroke or cryptogenic TIA and were und...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on